Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation

Author： Nussbaum Eric  

Publisher： Humana Press, Inc

ISSN： 1541-6933

Source： Neurocritical Care, Vol.10, Iss.1, 2009-02, pp. : 55-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 30, Iss. 6, 2015-06 ,pp. : 500-505

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 374-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 2, 2012-03 ,pp. : 139-150

Karger

Access to resources Recommend Favorite

Recombinant Activated Factor VII as a General Haemostatic Agent:Evidence-Based Efficacy and Safety

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 155-161

Bentham Science Publishers

Access to resources Recommend Favorite

Measures for risk factor stratification to prevent suicide mortality in breast cancer patients

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 27, Iss. 2, 2018-02 ,pp. : 706-706

John Wiley & Sons Inc

Access to resources Recommend Favorite